A new oral antiviral pill for Covid has been approved for use in the UK after it was found to be safe and effective.
The Medicines and Healthcare products Regulatory Agency (MHRA) found that the pill was effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are more at risk of becoming seriously ill.
Here's what you need to know about the new drug...
What is the new Covid pill?
The new pill which has been approved by the MHRA in the UK is called Lagevrio or molnupiravir.
Coming in pill form, the drug is for oral consumption and can be swallowed.
It works by stopping the virus from multiplying, causing Covid levels in the body to stay low and therefore preventing more serious illness.
Safety checks by two bodies, the MHRA and the government’s independent expert scientific advisory body, the Commission on Human Medicines, found that the drug reduced serious illness and hospitalisations in those most at risk.
The MHRA recommends the drug is used as soon as possible following a positive test result and within 5-days of symptoms starting.
It will be available soon for people who have mild to moderate COVID-19 and at least one risk factor for developing severe illness. Such risk factors include obesity, older age (>60 years), diabetes mellitus, or heart disease, as per authorisation.
The drug has been described as a "gamechanger for the most vulnerable and the immunosuppressed" by health secretary Sajid Javid.
When will the new Covid drug become available?
According to health secretary Sajid Javid, the government is "working at pace" and "with the NHS to set out plans to deploy molnupiravir to patients through a national study as soon as possible."
He added: "This antiviral will be an excellent addition to our armoury against COVID-19, and it remains vital everyone comes forward for their life-saving COVID-19 vaccine - particularly those eligible for a booster - to ensure as many people as possible are protected over the coming months."
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereLast Updated:
Report this comment Cancel